Luquiens A, Whalley D, Crawford S R, Laramée P, Doward L, Price M, Hawken N, Dorey J, Owens L, Llorca P M, Falissard B, Aubin H J
Département de psychiatrie et d'addictologie, INSERM U669, Hôpital Paul Brousse, Univ Paris Sud, APHP, Villejuif, France,
Qual Life Res. 2015 Jun;24(6):1471-81. doi: 10.1007/s11136-014-0865-7. Epub 2014 Nov 19.
The development of patient-centred approaches and of reduction in consumption strategies in alcohol use disorder requires giving a larger place to qualitative assessments that are closer to patients' concerns and more clinically relevant than drinking outcomes and generic health-related quality of life instrument. Our purpose was to develop from patients input the Alcohol Quality of Life Scale (AQoLS), a disease-specific measure for alcohol use disorder (AUD).
Concept elicitation focus groups were conducted with AUD patients in the UK and France. Thematic analysis was used to identify key areas of impact of AUD, and draft items were developed to capture these issues. The draft items underwent expert review to ensure clinical and cross-cultural applicability. Two iterative rounds of cognitive debriefing interviews were conducted with AUD patients in both countries, to assess face and content validity.
From focus groups conducted with 38 AUD patients, seven areas of impact emerged, forming the basis for the AQoLS: relationships, activities, looking after self, emotional impact, control, living conditions, and sleep. An initial pool of 90 items was reduced to 50 following the review process. In cognitive interviews, the measure took less than 10 min to complete, and patients reported that items were relevant to their experience. Following Round 1 interviews (n = 16), 14 items were removed because patients felt they were unclear or uneasy to respond to, 2 were combined, 7 were revised, and 4 new items were added. The recall period of 2 weeks was changed to 4 weeks, based on patient comments. Following Round 2 interviews (n = 15), 5 items were removed and 3 were modified to produce the 34-item AQoLS.
As the only de novo measure of health-related quality of life developed specifically for AUD, the AQoLS offers the potential of increased sensitivity to show the effectiveness of therapeutic interventions from the patient's perspective.
以患者为中心的方法的发展以及酒精使用障碍中减少消费策略的发展,需要给予定性评估更大的空间,这些定性评估比饮酒结果和一般健康相关生活质量工具更贴近患者的关注点且在临床上更具相关性。我们的目的是根据患者的意见开发酒精生活质量量表(AQoLS),这是一种针对酒精使用障碍(AUD)的疾病特异性测量工具。
在英国和法国对酒精使用障碍患者进行了概念启发焦点小组访谈。采用主题分析来确定酒精使用障碍的关键影响领域,并制定草稿条目以涵盖这些问题。草稿条目经过专家评审以确保临床和跨文化适用性。在两国对酒精使用障碍患者进行了两轮迭代的认知反馈访谈,以评估表面效度和内容效度。
在对38名酒精使用障碍患者进行的焦点小组访谈中,出现了七个影响领域,构成了AQoLS的基础:人际关系、活动、自我照顾、情绪影响、控制、生活条件和睡眠。经过评审过程,最初的90个条目的 pool 减少到了50个。在认知访谈中,该测量工具完成时间不到10分钟,患者报告说条目与他们的经历相关。在第一轮访谈(n = 16)后,14个条目被删除,因为患者觉得它们不清楚或难以回答,2个条目被合并,7个条目被修订,4个新条目被添加。根据患者的意见,回忆期从2周改为4周。在第二轮访谈(n = 15)后,5个条目被删除,3个条目被修改,从而产生了34个条目的AQoLS。
作为专门为酒精使用障碍开发的唯一全新的健康相关生活质量测量工具,AQoLS有可能提高敏感性,从患者的角度显示治疗干预的有效性。